BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32605627)

  • 1. Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis.
    Cheng JY; Liu CM; Wang YM; Hsu HC; Huang EY; Huang TT; Lee CH; Hung SP; Huang BS
    Radiat Oncol; 2020 Jun; 15(1):159. PubMed ID: 32605627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.
    Sanford NN; Pursley J; Noe B; Yeap BY; Goyal L; Clark JW; Allen JN; Blaszkowsky LS; Ryan DP; Ferrone CR; Tanabe KK; Qadan M; Crane CH; Koay EJ; Eyler C; DeLaney TF; Zhu AX; Wo JY; Grassberger C; Hong TS
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):64-72. PubMed ID: 30684667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Dosimetric Results of Proton or Photon Radiation Therapy for Large (>5 cm) Hepatocellular Carcinoma: A Retrospective Analysis.
    Hsieh RC; Lee CH; Huang HC; Wu SW; Chou CY; Hung SP; Lee CW; Krishnan S; Venkatesulu BP; Lee JC; Chou YC; Chan KM; Lin PT; Lee WC; Lin CC; Lin SY; Hong JH
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):712-724. PubMed ID: 37778426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
    Hsieh CE; Venkatesulu BP; Lee CH; Hung SP; Wong PF; Aithala SP; Kim BK; Rao A; Tung-Chieh Chang J; Tsang NM; Wang CC; Lee CC; Lin CC; Tseng JH; Chou WC; Wang YC; Krishnan S; Hong JH
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):73-86. PubMed ID: 30797890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the risk for radiation-induced liver disease following photon- or proton-beam radiosurgery of liver metastases.
    Mondlane G; Ureba A; Gubanski M; Lind PA; Siegbahn A
    Radiat Oncol; 2018 Oct; 13(1):206. PubMed ID: 30348194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of dosimetric variations of liver radiotherapy using deformable registration of planning CT and cone-beam CT.
    Huang P; Yu G; Chen J; Ma C; Qin S; Yin Y; Liang Y; Li H; Li D
    J Appl Clin Med Phys; 2017 Jan; 18(1):66-75. PubMed ID: 28291931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma.
    Taddei PJ; Howell RM; Krishnan S; Scarboro SB; Mirkovic D; Newhauser WD
    Phys Med Biol; 2010 Dec; 55(23):7055-65. PubMed ID: 21076199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma.
    Lin H; Li X; Liu Y; Hu Y
    ANZ J Surg; 2018 Oct; 88(10):E718-E724. PubMed ID: 29399938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer.
    Baumann BC; Mitra N; Harton JG; Xiao Y; Wojcieszynski AP; Gabriel PE; Zhong H; Geng H; Doucette A; Wei J; O'Dwyer PJ; Bekelman JE; Metz JM
    JAMA Oncol; 2020 Feb; 6(2):237-246. PubMed ID: 31876914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity-matched analysis of Surveillance, Epidemiology, and End Results database.
    Lin Q; Huang X; Zhong C; Luo T; Zeng X; Chen S
    Cancer Med; 2019 Feb; 8(2):515-526. PubMed ID: 30656831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liver.
    Lee CH; Hung SP; Hong JH; Chang JT; Tsang NM; Chan KM; Tseng JH; Huang SC; Lin SM; Lien JM; Liu NJ; Lin CC; Chen WT; Chen WY; Chen PJ; Huang BS
    PLoS One; 2018; 13(9):e0203854. PubMed ID: 30204800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution.
    Nakano R; Ohira M; Kobayashi T; Ide K; Tahara H; Kuroda S; Shimizu S; Kimura T; Nagata Y; Aikata H; Chayama K; Ohdan H
    Surgery; 2018 Aug; 164(2):219-226. PubMed ID: 29801728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of 1p/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon Therapy.
    Acharya S; Robinson CG; Michalski JM; Mullen D; DeWees TA; Campian JL; Chundury A; Bottani B; Hallahan DE; Bradley JD; Huang J
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):334-343. PubMed ID: 29534896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy.
    Toramatsu C; Katoh N; Shimizu S; Nihongi H; Matsuura T; Takao S; Miyamoto N; Suzuki R; Sutherland K; Kinoshita R; Onimaru R; Ishikawa M; Umegaki K; Shirato H
    Radiat Oncol; 2013 Mar; 8():48. PubMed ID: 23497543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical parameters for predicting radiation-induced liver disease after intrahepatic reirradiation for hepatocellular carcinoma.
    Huang Y; Chen SW; Fan CC; Ting LL; Kuo CC; Chiou JF
    Radiat Oncol; 2016 Jul; 11(1):89. PubMed ID: 27369241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early radiation-induced liver toxicities are associated with poor survival in patients with advanced hepatocellular carcinoma.
    Lai YL; Kuo YC; Lai HC; Peng CY; Wang YC; Liang JA; Chen SW
    Asia Pac J Clin Oncol; 2016 Dec; 12(4):437-443. PubMed ID: 26947774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Liver Imaging and Dosimetry to Predict Hepatotoxicity Risk in Cirrhotic Patients With Primary Liver Cancer.
    Schaub SK; Apisarnthanarax S; Price RG; Nyflot MJ; Chapman TR; Matesan M; Vesselle HJ; Bowen SR
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1339-1348. PubMed ID: 30170100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.
    Oshiro Y; Mizumoto M; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Takizawa D; Sakurai H
    Radiother Oncol; 2017 May; 123(2):240-245. PubMed ID: 28366501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Tsai SY; Cheng SH; Jian JJ; Huang AT
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):229-34. PubMed ID: 12694843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.